{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T09:26:19Z","timestamp":1789896379828,"version":"4.0.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2004,9,22]],"date-time":"2004-09-22T00:00:00Z","timestamp":1095811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2004,9,22]],"date-time":"2004-09-22T00:00:00Z","timestamp":1095811200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res"],"DOI":"10.1186\/bcr928","type":"journal-article","created":{"date-parts":[[2004,9,23]],"date-time":"2004-09-23T06:23:34Z","timestamp":1095920614000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["The progesterone receptor Val660\u2192Leu polymorphism and breast cancer risk"],"prefix":"10.1186","volume":"6","author":[{"given":"Immaculata","family":"De Vivo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan E","family":"Hankinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham A","family":"Colditz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J","family":"Hunter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2004,9,22]]},"reference":[{"key":"927_CR1","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1093\/aje\/152.10.950","volume":"152","author":"CA Colditz","year":"2000","unstructured":"Colditz CA, Rosner B: Cumulative risk of breast cancer to age 70 years according to risk factor status: data from the Nurses' Health Study. Am J Epidemiol. 2000, 152: 950-964. 10.1093\/aje\/152.10.950.","journal-title":"Am J Epidemiol"},{"key":"927_CR2","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1093\/jnci\/92.4.328","volume":"92","author":"RK Ross","year":"2000","unstructured":"Ross RK, Paganini-Hill A, Wan PC, Pike MC: Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin. J Natl Cancer Inst. 2000, 92: 328-332. 10.1093\/jnci\/92.4.328.","journal-title":"J Natl Cancer Inst"},{"key":"927_CR3","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1002\/j.1460-2075.1990.tb08280.x","volume":"9","author":"P Kastner","year":"1990","unstructured":"Kastner P, Krust A, Turcotte B, Stropp U, Tora L, Gronemeyer H, Chambon P: Two distinct estrogen-regulated promoters generate transcripts encoding the two functionally different human progesterone receptor forms A and B. EMBO J. 1990, 9: 1603-1614.","journal-title":"EMBO J"},{"key":"927_CR4","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/0006-291X(87)90395-0","volume":"149","author":"OM Conneely","year":"1987","unstructured":"Conneely OM, Maxwell BL, Toft DO, Schrader WT, O'Malley BW: The A and B forms of the chicken progesterone receptor arise by alternate initiation of translation of a unique mRNA. Biochem Biophys Res Commun. 1987, 149: 493-501.","journal-title":"Biochem Biophys Res Commun"},{"key":"927_CR5","doi-asserted-by":"crossref","first-page":"14062","DOI":"10.1016\/S0021-9258(18)71642-6","volume":"264","author":"OM Conneely","year":"1989","unstructured":"Conneely OM, Kettelberger DM, Tsai M-J, Schrader WT, O'Malley BW: The chicken progesterone receptor A and B isoforms are products of an alternate translation initiation event. J Biol Chem. 1989, 264: 14062-14064.","journal-title":"J Biol Chem"},{"key":"927_CR6","doi-asserted-by":"publisher","first-page":"8356","DOI":"10.1128\/MCB.14.12.8356","volume":"14","author":"DX Wen","year":"1994","unstructured":"Wen DX, You-Feng X, Mais DE, Goldman ME, McDonnell DP: The A and B isoforms of the human progesterone receptor operate through distinct signaling pathways within target cells. Mol Cell Biol. 1994, 14: 8356-8364.","journal-title":"Mol Cell Biol"},{"key":"927_CR7","first-page":"1347","volume":"8","author":"CA Sartorius","year":"1994","unstructured":"Sartorius CA, Melville MY, Hovland AR, Tung L, Takimoto GS, Horwitz KB: A third transactivation function (AF3) of human progesterone receptors located in the unique N-terminal segment of the B-isoform. Mol Endocrinol. 1994, 8: 1347-1360. 10.1210\/me.8.10.1347.","journal-title":"Mol Endocrinol"},{"key":"927_CR8","doi-asserted-by":"publisher","first-page":"3102","DOI":"10.1128\/MCB.20.9.3102-3115.2000","volume":"20","author":"PH Giangrande","year":"2000","unstructured":"Giangrande PH, Kimbrel EA, Edwards DP, McDonnell DP: The opposing transcriptional activities of the two isoforms of the human progesterone receptor are due to differential cofactor binding. Mol Cell Biol. 2000, 20: 3102-3115. 10.1128\/MCB.20.9.3102-3115.2000.","journal-title":"Mol Cell Biol"},{"key":"927_CR9","first-page":"146","volume":"13","author":"KB Horwitz","year":"1992","unstructured":"Horwitz KB: The molecular biology of RU486. Is there a role for antiprogestins in the treatment of breast cancer?. Endocr Rev. 1992, 13: 146-163. 10.1210\/er.13.2.146.","journal-title":"Endocr Rev"},{"key":"927_CR10","doi-asserted-by":"publisher","first-page":"5209","DOI":"10.1074\/jbc.M110090200","volume":"277","author":"JK Richer","year":"2002","unstructured":"Richer JK, Jacobsen BM, Manning NG, Abel MG, Wolf DM, Horwitz KB: Differential gene regulation by the two progesterone receptor isoforms in human breast cancer cells. J Biol Chem. 2002, 277: 5209-5218. 10.1074\/jbc.M110090200.","journal-title":"J Biol Chem"},{"key":"927_CR11","doi-asserted-by":"publisher","first-page":"2266","DOI":"10.1101\/gad.9.18.2266","volume":"9","author":"JP Lydon","year":"1995","unstructured":"Lydon JP, DeMayo FJ, Funk CR, Mani SK, Hughes AR, Montgomery CA, Shyamala G, Conneely OM, O'Malley BW: Mice lacking progesterone receptor exhibit pleiotropic reproductive abnormalities. Genes Dev. 1995, 9: 2266-2278.","journal-title":"Genes Dev"},{"key":"927_CR12","first-page":"4276","volume":"59","author":"JP Lydon","year":"1999","unstructured":"Lydon JP, Ge G, Kittrell FS, Medina D, O'Malley BW: Murine mammary gland carcinogenesis is critically dependent on progesterone receptor function. Cancer Res. 1999, 59: 4276-4284.","journal-title":"Cancer Res"},{"key":"927_CR13","doi-asserted-by":"publisher","first-page":"9744","DOI":"10.1073\/pnas.1732707100","volume":"100","author":"B Mulac-Jericevic","year":"2003","unstructured":"Mulac-Jericevic B, Lydon JP, DeMayo FJ, Conneely OM: Defective mammary gland morphogenesis in mice lacking the progesterone receptor B isoform. Proc Natl Acad Sci U S A. 2003, 100: 9744-9749. 10.1073\/pnas.1732707100.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"927_CR14","doi-asserted-by":"publisher","first-page":"12263","DOI":"10.1073\/pnas.192172299","volume":"99","author":"I De Vivo","year":"2002","unstructured":"De Vivo I, Huggins GS, Hankinson SE, Lescault PJ, Boezen M, Colditz GA, Hunter DJ: A functional polymorphism in the promoter of the progesterone receptor gene associated with endometrial cancer risk. Proc Natl Acad Sci U S A. 2002, 99: 12263-12268. 10.1073\/pnas.192172299.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"927_CR15","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1038\/bjc.1997.238","volume":"75","author":"TP Manolitsas","year":"1997","unstructured":"Manolitsas TP, Englefield P, Eccles DM, Campbell IG: No association of a 306-bp insertion polymorphism in the progesterone receptor gene with ovarian and breast cancer. Br J Cancer. 1997, 75: 1398-1399.","journal-title":"Br J Cancer"},{"key":"927_CR16","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/bjc.1998.480","volume":"78","author":"JM Lancaster","year":"1998","unstructured":"Lancaster JM, Berchuck A, Carney ME, Wiseman R, Taylor JA: Progesterone receptor gene polymorphism and risk for breast and ovarian cancer. Br J Cancer. 1998, 78: 277-","journal-title":"Br J Cancer"},{"key":"927_CR17","first-page":"2348","volume":"60","author":"S Wang-Gohrke","year":"2000","unstructured":"Wang-Gohrke S, Chang-Claude J, Becher H, Kieback DG, Runnebaum IB: Progesterone receptor gene polymorphism is associated with decreased risk for breast cancer by age 50. Cancer Res. 2000, 60: 2348-2350.","journal-title":"Cancer Res"},{"key":"927_CR18","first-page":"5236","volume":"63","author":"I De Vivo","year":"2003","unstructured":"De Vivo I, Hankinson SE, Colditz GA, Hunter DJ: A functional polymorphism in the progesterone receptor gene is associated with an increase in breast cancer risk. Cancer Res. 2003, 63: 5236-5238.","journal-title":"Cancer Res"},{"key":"927_CR19","first-page":"439","volume":"11","author":"AB Spurdle","year":"2002","unstructured":"Spurdle AB, Hopper JL, Chen X, McCredie MR, Giles GG, Venter DJ, Southey MC, Chenevix-Trench G: The progesterone receptor exon 4 val660leu G\/T polymorphism and risk of breast cancer in Australian women. Cancer Epidemiol Biomarkers Prev. 2002, 11: 439-443.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"927_CR20","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1023\/A:1014813931765","volume":"72","author":"G Fabjani","year":"2002","unstructured":"Fabjani G, Tong D, Czerwenka K, Schuster E, Speiser P, Leodolter S, Zeillinger R: Human progesterone receptor gene polymorphism PROGINS and risk for breast cancer in Austrian women. Breast Cancer Res Treat. 2002, 72: 131-137. 10.1023\/A:1014813931765.","journal-title":"Breast Cancer Res Treat"}],"container-title":["Breast Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/bcr928.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/bcr928\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/bcr928.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,25]],"date-time":"2024-04-25T16:31:08Z","timestamp":1714062668000},"score":1,"resource":{"primary":{"URL":"https:\/\/breast-cancer-research.biomedcentral.com\/articles\/10.1186\/bcr928"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,9,22]]},"references-count":20,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2004,12]]}},"alternative-id":["927"],"URL":"https:\/\/doi.org\/10.1186\/bcr928","relation":{},"ISSN":["1465-542X"],"issn-type":[{"value":"1465-542X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,9,22]]},"assertion":[{"value":"16 April 2004","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2004","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2004","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2004","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}],"article-number":"R636"}}